MDPI and ACS Style
Bertrand, J.; Dostálová, H.; Kryštof, V.; Jorda, R.; Delgado, T.; Castro-Alvarez, A.; Mella, J.; Cabezas, D.; Faúndez, M.; Espinosa-Bustos, C.;
et al. Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics 2022, 14, 1294.
https://doi.org/10.3390/pharmaceutics14061294
AMA Style
Bertrand J, Dostálová H, Kryštof V, Jorda R, Delgado T, Castro-Alvarez A, Mella J, Cabezas D, Faúndez M, Espinosa-Bustos C,
et al. Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics. 2022; 14(6):1294.
https://doi.org/10.3390/pharmaceutics14061294
Chicago/Turabian Style
Bertrand, Jeanluc, Hana Dostálová, Vladimír Kryštof, Radek Jorda, Thalía Delgado, Alejandro Castro-Alvarez, Jaime Mella, David Cabezas, Mario Faúndez, Christian Espinosa-Bustos,
and et al. 2022. "Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia" Pharmaceutics 14, no. 6: 1294.
https://doi.org/10.3390/pharmaceutics14061294